• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22099 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2024     NIHR Health Technology Assessment programme Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)
2002     NIHR Health Technology Assessment programme What is the value to society of a QALY: an investigation among the public in England and Wales
2010     NIHR Health Technology Assessment programme Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
2014     NIHR Health Technology Assessment programme Eculizumab for treating atypical haemolytic uraemic syndrome
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2024     NIHR Health Technology Assessment programme Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation
2002     NIHR Health Technology Assessment programme A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists
2005     NIHR Health Technology Assessment programme Issues in data monitoring and interim analysis of trials
2009     NIHR Health Technology Assessment programme Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation
2010     NIHR Health Technology Assessment programme Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis
2013     NIHR Health Technology Assessment programme Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
2015     NIHR Health Technology Assessment programme Vortioxetine for treating major depressive disorder
2021     NIHR Health Technology Assessment programme Minimally invasive thoracoscopically-guided right minithoracotomy versus conventional sternotomy for mitral valve repair: a multicentre randomised controlled trial (UK Mini Mitral)
2024     NIHR Health Technology Assessment programme Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
2001     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimers disease: a rapid and systematic review
2005     NIHR Health Technology Assessment programme Lay public's understanding of equipoise and randomisation in randomised controlled trials
2007     NIHR Health Technology Assessment programme Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme A randomised controlled trial to compare minimally invasive glucose monitoring devices to conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE)
2016     NIHR Health Technology Assessment programme The Head Injury Transportation Straight to Neurosurgery (HITS-NS) randomised trial: a feasibility study
2010     NIHR Health Technology Assessment programme Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
2013     NIHR Health Technology Assessment programme Ustekinumab for treating active and progressive psoriatic arthritis
2018     NIHR Health Technology Assessment programme Factors associated with hospital emergency readmission and mortality rates in patients with heart failure or chronic obstructive pulmonary disease: a national observational study
2021     NIHR Health Technology Assessment programme Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM) trial
2024     NIHR Health Technology Assessment programme KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review
2001     NIHR Health Technology Assessment programme Eliciting public preferences for healthcare: a systematic review of techniques
2004     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
2004     NIHR Health Technology Assessment programme What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
2014     NIHR Health Technology Assessment programme Can rapid integrated Polymerase Chain Reaction (PCR)-based diagnostics for Gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study
2013     NIHR Health Technology Assessment programme Bosutinib for previously treated chronic myeloid leukaemia: a single technology appraisal
2021     NIHR Health Technology Assessment programme Understanding health-care outcomes of older people with cognitive impairment and/or dementia admitted to hospital: a mixed-methods study
2021     NIHR Health Technology Assessment programme Antidepressants to prevent relapse in depression
2001     NIHR Health Technology Assessment programme An assessment of screening strategies for fragile X syndrome in the UK
2004     NIHR Health Technology Assessment programme Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation
2003     NIHR Health Technology Assessment programme Scoping study on the assessment of the star ratings
2013     NIHR Health Technology Assessment programme Teriflunomide for treating relapsing forms of multiple sclerosis
2018     NIHR Health Technology Assessment programme Interventions to improve antimicrobial prescribing of doctors in training (IMPACT): a realist review
2022     NIHR Health Technology Assessment programme Antibiotics for lower respiratory tract infection in children presenting in primary care (ARTIC PC)
2015     NIHR Health Technology Assessment programme Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme
2021     NIHR Health Technology Assessment programme BioImpedance Spectroscopy To maintain Renal Output: the BISTRO trial
2001     NIHR Health Technology Assessment programme Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review
2004     NIHR Health Technology Assessment programme Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment
2006     NIHR Health Technology Assessment programme Exploring the determinants of NHS performance ratings: lessons for performance assessment systems
2014     NIHR Health Technology Assessment programme The clinical and cost effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2013     NIHR Health Technology Assessment programme Dimethyl fumarate for treating relapsing-remitting multiple sclerosis
2019     NIHR Health Technology Assessment programme Developing and evaluating a tool to measure general practice productivity: a multimethod study
2001     NIHR Health Technology Assessment programme Statistical assessment of the learning curves of health technologies
2002     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: a systematic review
2004     NIHR Health Technology Assessment programme Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups
2007     NIHR Health Technology Assessment programme A systematic review and economic evaluation of statins for the prevention of coronary events
2004     NIHR Health Technology Assessment programme Methods for identifying and classifying surgical site infection after discharge from hospital
2015     NIHR Health Technology Assessment programme Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation
2014     NIHR Health Technology Assessment programme Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases
2019     NIHR Health Technology Assessment programme Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2000     NIHR Health Technology Assessment programme A systematic review of treatments for severe psoriasis
2003     NIHR Health Technology Assessment programme A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2007     NIHR Health Technology Assessment programme A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carer
2015     NIHR Health Technology Assessment programme Developing and piloting a peer mentoring intervention to reduce teenage pregnancy in looked-after children and care leavers: an exploratory randomised controlled trial
2014     NIHR Health Technology Assessment programme Enzalutamide for the treatment of metastatic hormone relapsed prostate cancer previously treated with a docetaxel-containing regimen
2022     NIHR Health Technology Assessment programme Evaluation of the Healthy Start Voucher Scheme in UK: a natural experiment using the Growing Up in Scotland record linkage study and the Infant Feeding Survey
2002     NIHR Health Technology Assessment programme Treatment of established osteoporosis: a systematic review and cost-utility analysis
2007     NIHR Health Technology Assessment programme Additional therapy for young children with spastic cerebral palsy: a randomised controlled trial
2015     NIHR Health Technology Assessment programme Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation
2013     NIHR Health Technology Assessment programme Bortezomib for induction therapy in multiple myeloma before high dose chemotherapy and autologous stem cell transplantation
2017     NIHR Health Technology Assessment programme Managing diabetes in people with dementia: a realist review
2003     NIHR Health Technology Assessment programme A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of womens preferences in the management of menorrhagia
2004     NIHR Health Technology Assessment programme Involving South Asian patients in clinical trials
2007     NIHR Health Technology Assessment programme Screening for type 2 diabetes: literature review and economic modelling
2004     NIHR Health Technology Assessment programme The value of a QALY implied by the value of a 'statistical life' in the field of transport
2016     NIHR Health Technology Assessment programme Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers
2016     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model
2014     NIHR Health Technology Assessment programme The effectiveness of collaborative care for people with memory problems in primary care: results of the CAREDEM case management modelling and feasibility study
2022     NIHR Health Technology Assessment programme DexEnceph- Dexamethasone in Herpes Simplex Virus Encephalitis Randomised Controlled Trial and NonHSV Cohort Study
2021     NIHR Health Technology Assessment programme Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation
2004     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes
2007     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials
2014     NIHR Health Technology Assessment programme Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study
2018     NIHR Health Technology Assessment programme A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study
2011     NIHR Health Technology Assessment programme A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET)
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation
2005     NIHR Health Technology Assessment programme Testing treatments on animals: relevance to humans
2015     NIHR Health Technology Assessment programme Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
2013     NIHR Health Technology Assessment programme Bendamustine in combination with rituximab for the first-line treatment of indolent non-Hodgkin's lymphoma
2014     NIHR Health Technology Assessment programme The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy - clinical effectiveness and safety until 2 years after delivery, with economic evaluation
2017     NIHR Health Technology Assessment programme Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
2014     NIHR Health Technology Assessment programme The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy; effectiveness and safety until 2 years after delivery, with economic evaluation
2017     NIHR Health Technology Assessment programme The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations
2007     NIHR Health Technology Assessment programme A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease
2005     NIHR Health Technology Assessment programme A review of, and primary research into, approaches to the elicitation of individuals' (Bayesian) prior probabilities
2015     NIHR Health Technology Assessment programme The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
2013     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of rifaximin for maintaining remission from episodes of hepatic encephalopathy
2014     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2018     NIHR Health Technology Assessment programme Nurse staffing levels, missed vital signs and mortality in hospitals: retrospective longitudinal observational study.
2014     NIHR Health Technology Assessment programme Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year olds